NASDAQ:SLS
SELLAS Life Sciences Group, Inc.
- Stock
Last Close
1.16
26/07 20:00
Market Cap
67.00M
Beta: 2.25
Volume Today
317.24K
Avg: 476.91K
PE Ratio
−0.45
PFCF: −0.72
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 193K - | 520.50K 169.69% | 327.50K 37.08% | 286.50K - | 519K 81.15% | 232.50K 55.20% | ||||||
average payables | 3.34M - | 2.47M 26.12% | 1.93M 21.56% | 1.22M 37.00% | 6.27M 414.20% | 7.72M 23.26% | 3.83M 50.43% | 4.28M 11.78% | 3.40M 20.54% | 2.75M 19.11% | 4.50M 63.53% | |
average receivables | 1.84M - | 2.76M 49.93% | 919.50K 66.70% | 154K - | 718K 366.23% | 564K 21.45% | ||||||
book value per share | 1.96K - | 9.31K 375.65% | 2.61K 71.96% | 4.32K 65.31% | 44.22 98.98% | 20.05 54.65% | 2.38 88.13% | 3.51 47.20% | 1.31 62.50% | 0.25 80.97% | -0.29 214.81% | |
capex per share | -5.27K - | -1.39K 73.65% | -29.57 97.87% | -0.90 96.94% | -0.23 - | -0.20 14.66% | ||||||
capex to depreciation | -35.06 - | -6.22 82.27% | -0.43 93.07% | -0.04 90.20% | ||||||||
capex to operating cash flow | 0.55 - | 0.13 76.48% | 0.00 97.54% | 0.00 95.80% | 0.19 - | 0.18 7.35% | ||||||
capex to revenue | -6.37 - | -0.59 90.69% | -4.50 - | |||||||||
cash per share | 15.90K - | 5.94K 62.61% | 5.74K 3.34% | 2.72K 52.59% | 49.54 98.18% | 20.41 58.81% | 2.84 86.06% | 4.43 55.61% | 1.38 68.83% | 0.88 35.99% | 0.09 89.28% | |
days of inventory on hand | 270.94 - | 170.40 37.11% | ||||||||||
days payables outstanding | 1.87K - | 590.82 68.36% | 3.91K - | 12.25K 213.15% | ||||||||
days sales outstanding | 540.53 - | 72.03 86.67% | 216.69 - | |||||||||
debt to assets | 0.11 - | 0.10 7.46% | 0.06 44.73% | 0.25 331.87% | 0.33 31.54% | 0.01 - | 0.02 64.72% | 0.03 42.89% | 0.05 46.73% | 0.07 54.37% | ||
debt to equity | 1.69 - | 0.23 86.55% | 0.35 54.68% | 0.57 63.15% | 5.31 827.72% | 0.04 - | 0.04 0.48% | 0.04 12.04% | 0.19 390.56% | -0.06 128.70% | ||
dividend yield | 0.04 - | 0.03 18.12% | ||||||||||
earnings yield | -0.17 - | -0.20 18.47% | -0.28 37.87% | -1.22 335.32% | -1.30 6.75% | -1.72 32.20% | -1.75 1.93% | -0.36 79.38% | -0.24 33.13% | -0.89 267.32% | -1.27 42.80% | |
enterprise value | 409.43M - | 165.00M 59.70% | 203.23M 23.17% | 17.63M 91.32% | 26.92M 52.69% | 10.75M 60.08% | 3.94M 63.32% | 12.04M 205.28% | 65.06M 440.58% | 29.59M 54.52% | 27.72M 6.33% | |
enterprise value over ebitda | 53.67 - | -2.41 104.50% | -6.75 179.63% | -0.31 95.37% | -1.40 346.69% | -0.32 76.96% | -0.26 17.92% | -0.71 169.89% | -2.19 207.83% | -0.70 68.11% | -0.73 4.58% | |
ev to operating cash flow | -14.16 - | -3.85 72.82% | -4.22 9.64% | -0.39 90.70% | -2.45 524.07% | -0.35 85.58% | -0.22 36.75% | -1.16 417.04% | -2.50 116.41% | -1.24 50.29% | -0.88 29.00% | |
ev to sales | 164.63 - | 17.71 89.24% | 6.33 - | 8.56 35.14% | 29.59 245.68% | |||||||
free cash flow per share | -14.89K - | -12.16K 18.31% | -9.34K 23.24% | -6.77K 27.52% | -234.77 96.53% | -116.32 50.46% | -6.90 94.07% | -1.31 81.06% | -1.68 28.71% | -1.46 13.16% | -1.33 8.96% | |
free cash flow yield | -0.10 - | -0.27 168.34% | -0.21 21.16% | -2.33 998.34% | -0.60 74.11% | -1.89 214.19% | -1.60 15.22% | -0.22 85.98% | -0.30 35.23% | -0.62 103.47% | -1.25 102.70% | |
graham net net | -10.43K - | -4.54K 56.45% | -7.52K 65.51% | -2.87K 61.79% | -622.49 78.33% | -24.21 96.11% | -1.06 95.61% | 2.29 315.60% | 1.00 56.54% | 0.05 94.66% | -0.42 894.18% | |
graham number | 33.52K - | 43.91K 30.98% | 26.93K 38.66% | 18.56K 31.09% | 710.61 96.17% | 218.49 69.25% | 20.10 90.80% | 12.87 35.96% | 6.29 51.15% | 3.43 45.38% | 2.95 14.19% | |
income quality | 0.38 - | 1.17 210.63% | 1.24 5.57% | 4.05 227.28% | 0.46 88.57% | 1.10 137.66% | 0.91 16.82% | 0.62 32.02% | 1.26 102.22% | 0.58 54.14% | 0.84 45.92% | |
intangibles to total assets | 0.38 - | 0.63 64.64% | 0.34 45.98% | 0.43 24.82% | 0.58 36.72% | 0.62 5.77% | 0.46 25.54% | 0.17 63.93% | 0.07 55.94% | 0.09 25.46% | 0.30 227.08% | |
interest coverage | -41.93 - | -47.05 12.20% | -45.03 4.29% | -9.08 79.82% | -49.87 448.96% | -116.88 134.37% | -169.84 45.32% | 64.64 - | ||||
interest debt per share | 3.57K - | 2.39K 33.04% | 1.06K 55.55% | 3.00K 182.15% | 244.62 91.84% | 1.02 99.58% | 0.13 87.13% | 0.12 5.11% | 0.05 57.99% | 0.02 70.76% | 0.02 5.21% | |
inventory turnover | 1.35 - | 2.14 59.00% | ||||||||||
invested capital | 1.69 - | 0.23 86.55% | 0.35 54.68% | 0.57 63.15% | 5.31 827.72% | 0.04 - | 0.04 0.48% | 0.04 12.04% | 0.19 390.56% | -0.06 128.70% | ||
market cap | 447.29M - | 180.25M 59.70% | 228.22M 26.61% | 19.32M 91.53% | 18.25M 5.51% | 16.08M 11.89% | 11.00M 31.60% | 46.35M 321.23% | 85.61M 84.72% | 45.77M 46.53% | 29.44M 35.68% | |
net current asset value | -28.64M - | -14.40M 49.69% | -15.01M 4.20% | 345K 102.30% | -18.37M 5,424.35% | -5.83M 68.25% | -2.27M 61.01% | 18.84M 928.36% | 17.12M 9.14% | 1.66M 90.28% | -11.21M 773.50% | |
net debt to ebitda | -4.96 - | 0.22 104.50% | 0.83 272.11% | 0.03 96.40% | -0.45 1,604.24% | 0.16 135.53% | 0.47 196.00% | 2.03 329.65% | 0.69 65.90% | 0.38 44.79% | 0.05 88.10% | |
net income per share | -25.51K - | -9.20K 63.93% | -12.35K 34.22% | -3.55K 71.27% | -507.49 85.69% | -105.80 79.15% | -7.54 92.87% | -2.10 72.14% | -1.34 36.35% | -2.10 56.76% | -1.34 35.86% | |
operating cash flow per share | -9.62K - | -10.77K 12.03% | -9.31K 13.62% | -6.77K 27.30% | -234.77 96.53% | -116.32 50.46% | -6.90 94.07% | -1.31 81.06% | -1.68 28.71% | -1.23 26.97% | -1.13 7.88% | |
payables turnover | 0.20 - | 0.62 216.02% | 0.09 - | 0.03 68.07% | ||||||||
receivables turnover | 0.68 - | 5.07 650.44% | 1.68 - | |||||||||
research and ddevelopement to revenue | 8.47 - | 3.04 64.10% | 4.89 - | 2.81 42.43% | 30.27 976.25% | |||||||
return on tangible assets | -1.41 - | -1.23 12.72% | -1.18 4.32% | -0.62 47.22% | -1.70 172.07% | -4.26 151.07% | -2.14 49.61% | -0.44 79.67% | -0.85 94.89% | -2.14 151.43% | -8.32 289.37% | |
revenue per share | 827.35 - | 2.34K 183.08% | 0.24 - | 0.49 106.11% | 0.05 89.50% | |||||||
roe | -13.03 - | -0.99 92.42% | -4.73 378.74% | -0.82 82.62% | -11.48 1,296.45% | -5.28 54.03% | -3.17 39.98% | -0.60 81.07% | -1.02 69.75% | -8.38 723.76% | 4.68 155.86% | |
roic | -2.17 - | -0.66 69.34% | -1.89 185.02% | -0.72 61.79% | -1.78 146.61% | -5.65 216.60% | -3.06 45.85% | -0.57 81.47% | -1.14 100.97% | -6.13 437.96% | 5.36 187.45% | |
sales general and administrative to revenue | 5.87 - | 3.36 42.71% | 5.05 - | 1.49 70.52% | 12.58 744.73% | |||||||
shareholders equity per share | 1.96K - | 9.31K 375.65% | 2.61K 71.96% | 4.32K 65.31% | 44.22 98.98% | 20.05 54.65% | 2.38 88.13% | 3.51 47.20% | 1.31 62.50% | 0.25 80.97% | -0.29 214.81% | |
stock based compensation to revenue | 1.02 - | 0.58 43.18% | 0.30 - | 0.13 56.27% | 1.73 1,197.49% | |||||||
tangible asset value | -27.86M - | -13.76M 50.59% | -14.50M 5.38% | 640K 104.41% | -17.44M 2,825.63% | -5.17M 70.37% | -1.52M 70.57% | 20.35M 1,437.74% | 18.43M 9.41% | 2.94M 84.07% | -9.89M 436.74% | |
tangible book value per share | -9.27K - | -3.46K 62.67% | -2.80K 18.97% | 96.40 103.44% | -372.68 486.60% | -19.76 94.70% | -0.59 96.99% | 2.55 529.10% | 1.19 53.32% | 0.15 87.28% | -0.36 335.13% | |
working capital | -8.99M - | 1.79M 119.92% | -3.45M 292.63% | 7.10M 305.83% | -11.48M 261.70% | -136K 98.82% | 2.95M 2,270.59% | 24.59M 732.96% | 18.06M 26.54% | 2.24M 87.59% | -10.56M 571.35% |
All numbers in USD (except ratios and percentages)